Cardiovascular Systems to Present at the JMP Securities Life Sciences Conference
June 14 2017 - 4:05PM
Business Wire
On Wednesday, June 21, 2017, Cardiovascular Systems’ (NASDAQ:
CSII) Chief Financial Officer, Larry Betterley, will present at the
JMP Securities Life Sciences Conference at 11:30 a.m. Eastern
Time.
You may access the live audio webcast and presentation materials
in the events section of the company’s investor relations website,
http://investors.csi360.com/Investors/Events.
About Cardiovascular Systems,
Inc.Cardiovascular Systems, Inc., based in St. Paul, Minn., is
a medical device company focused on developing and commercializing
innovative solutions for treating vascular and coronary disease.
The company’s Orbital Atherectomy Systems treat calcified and
fibrotic plaque in arterial vessels throughout the leg and heart in
a few minutes of treatment time, and address many of the
limitations associated with existing surgical, catheter and
pharmacological treatment alternatives. The U.S. FDA granted the
first 510(k) clearance for the use of the Orbital Atherectomy
System in peripheral arteries in August 2007. In October 2013, the
company received FDA approval for the Coronary Orbital Atherectomy
System. To date, over 308,000 of CSI’s devices have been sold to
leading institutions across the United States. For more
information, visit the company’s website at www.csi360.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170614005129/en/
Cardiovascular Systems, Inc.Jack Nielsen,
651-202-4919j.nielsen@csi360.comorPadillaMatt Sullivan,
612-455-1709matt.sullivan@padillaco.com
Cardiovascular Systems (NASDAQ:CSII)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cardiovascular Systems (NASDAQ:CSII)
Historical Stock Chart
From Sep 2023 to Sep 2024